ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
What’s reshaping nuclear licensing and compliance today?
Mark Reidmeyer
It is the convergence of urgency, innovation, and modernization that is reshaping nuclear licensing and compliance today.
For decades, nuclear licensing operated in a relatively stable environment built around large light water reactors, predictable review cycles, and well-established regulatory pathways. Today, that model is evolving rapidly. Advanced reactors, AI-enabled tools, digital engineering platforms, grid reliability concerns, and aggressive decarbonization goals are all pushing the industry—and regulators—to move faster and think differently.
J. R. Divine
Nuclear Technology | Volume 18 | Number 2 | May 1973 | Pages 171-176
Technical Paper | A Review of Plutonium Utilization in Thermal Reactors / Reactor | doi.org/10.13182/NT73-A31285
Articles are hosted by Taylor and Francis Online.
In the next five to ten years, the use of plutonium-enriched fuels is expected to increase significantly. As is the case with irradiated uranium-only fuels, radiation levels within the reactor system can be expected to increase in the event of a severe fuel failure. The in-reactor dissolution of mixed-oxide UO2-PuO2 fuels has been reviewed with consideration of past experience and potentially useful decontamination solutions. The currently most suitable decontamination agent of mixed oxides is a solution of buffered oxalic acid/hydrogen peroxide/gluconic acid (OPG).